With a fresh expansion of its production capacity, supported by a strong commitment to operational excellence, Rousselot is ideally positioned to deliver premium quality porcine collagen ingredients to the global food market, as well as to the rapidly growing nutritional supplements sector.
Rousselot, Darling Ingredients’ health brand, and the global leader of collagen-based solutions, announces an increase in its production capabilities for porcine collagen, responding to rising demand for premium collagen ingredients.
The newly opened production line in Ghent, Belgium will specialise in the manufacture of Peptan P - the leading collagen peptide brand.
This new line complements Rousselot’s existing bovine and fish collagen production capabilities and will improve manufacturers’ access to premium collagen ingredients and speed to market capabilities.
Diversifying production with quality porcine collagen
Consumer interest in collagen-based supplements is increasing around the world, with the category seeing a threefold increase in product launches from 2017 – 2021.
To help nutraceutical manufacturers capitalise on these market trends, Rousselot has increased its collagen peptide production facilities from two in 2019, to four sites; Angoulême (France), Amparo and Presidente Epitácio (Brazil), and now, a dedicated premium porcine collagen (Peptan P) production facility in Ghent (Belgium).
This IFS, FASFC and HACCP certified site, has specialised in porcine collagen extraction since 1962, is one of the largest sites of this kind in the world, and now produces premium porcine collagen peptides according to the highest standards of quality and safety.
Also housed alongside the new production line at the Ghent site is Rousselot’s Global Expertise Center, where science and innovation teams harness R&D and application labs, a sensory program and a pilot hall to drive the organisation’s innovation pipeline.
Addressing global demand with accessible solutions
The supply of beef and fish collagen has met with massive success in recent years.
However, there is an opportunity for porcine collagen to take a more prominent role in the nutraceutical market.
Rousselot’s premium porcine collagen brand, Peptan P, offers an accessible, effective and adaptable ingredient as an alternative source of high-quality collagen.
The raw materials used to manufacture Peptan P are traceable to within four hours of the supplier, consisting of GMO-free pork sourced exclusively from registered European farms, audited by Rousselot.
This commitment to complete traceability gives nutraceutical manufacturers valuable information on the origin species, quality and safety of their collagen ingredients.
Beyond offering producers complete peace of mind, Peptan P presents a versatile, cost-effective collagen peptide solution with a range of functional claims.
By incorporating the ingredient into their offering, nutraceutical manufacturers can take advantage of the range of science-backed benefits the Peptan brand provides.
Additionally, Peptan P is highly bioavailable, cold water-soluble and with a completely neutral sensory profile, there are virtually no limits to its potential in food, beverage and nutraceutical applications.
New perspectives in collagen solutions
Gaetan Noiret, Global Director, Health and Nutrition at Rousselot comments, “The addition of a new production line allows us to reach further with our customers, delivering the safe, traceable and science-backed collagen solutions they need to succeed in today’s market.”
Noiret continues, “Our Ghent facility is perfectly positioned to produce first class collagen peptides of porcine origin - giving manufacturers the opportunity to diversify their offerings with accessible, world-leading ingredients supported by credible scientific research – ensuring a speedy path to market.”
To help manufacturers discover the many advantages high-quality collagen peptides can bring to their applications, Rousselot invites you to register for an expert webinar - New perspectives in the collagen world: premium porcine collagen peptides - scheduled to take place on 22nd February 2022.